A. Rivlin

A. Rivlin has extensive work experience in the field of scientific research and development. They began their career at Howard Hughes Medical Institute/UCLA in 1999 as a PostDoc, where they focused on developing RNA editing assays and studying the enzymes involved in RNA editing.

After their role at Howard Hughes Medical Institute/UCLA, A. Rivlin worked as an Independent Consultant and Scientist I, II at Ingenuity Systems from 2001 to 2003.

They then joined ThauMDx/Biocentrix as a Scientist from 2002 to 2003, followed by a position as a Scientist I, II at Monsanto from 2003 to 2013. At Monsanto, they led and contributed to the development of multiple processes and products, with a focus on analytical support, and received multiple corporate awards for their performance.

Following their time at Monsanto, A. Rivlin worked as a Consultant at BioAdept in 2013, before transitioning to Hologic, Inc. as a Senior Staff Scientist from 2014 to 2019. At Hologic, Inc., they provided manufacturing support for nucleic acid-based diagnostic assays for infectious diseases, and were involved in various functions such as assay development, verification and validation, process improvement, and troubleshooting.

In 2019, A. Rivlin joined bioMérieux as a Principal Scientist, where they worked until 2021. They then moved to aTyr Pharma, where they held the role of Principal Scientist, Process Sciences from 2021 to 2022.

Most recently, A. Rivlin worked at Abbott as a Principal Scientist in Applied Research from 2022 to 2023. They are currently employed as a Product Development Manager at Invivoscribe since April 2023.

A. Rivlin obtained a Doctor of Philosophy (PhD) degree in Biochemistry and Molecular Biology from the University of Chicago, where they studied from 1994 to 1999. Apart from their doctoral degree, no information is provided about any additional certifications or education experiences, such as the obtained month or year for the Six Sigma Certification - Green Belt from the University of Wisconsin, Madison, WI.